Logo
x

Search

Subscribe Now

Trials

GSK Discontinues the P-II Trials of Feladilimab for Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

GSK Discontinues the P-II Trials of Feladilimab for Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

  • April 16, 2021
Thermo Fisher Expands its Direct-to-Patient Service Offerings

Thermo Fisher Expands its Direct-to-Patient Service Offerings

  • October 28, 2020
AstraZeneca Resumes COVID-19 Vaccine Trials in the UK

AstraZeneca Resumes COVID-19 Vaccine Trials in the UK

  • September 14, 2020
Novartis Reports Results of Ofatumumab (OMB157) in P-III ASCLEPIOS Trials for Relapsing Multiple Sclerosis

Novartis Reports Results of Ofatumumab (OMB157) in P-III ASCLEPIOS Trials for Relapsing Multiple Sclerosis

  • August 6, 2020
Sol-Gel Reports Results of Twyneo in Two P-III Trials for Acne Vulgaris

Sol-Gel Reports Results of Twyneo in Two P-III Trials for Acne Vulgaris

  • January 2, 2020
Sun Pharma Reports Four Years Result of Ilumya (tildrakizumab-asmn) in P-III reSURFACE 1 and 2 Trials in Patients with Moderate-to-Severe Plaque Psoriasis

Sun Pharma Reports Four Years Result of Ilumya (tildrakizumab-asmn) in P-III reSURFACE 1 and 2 Trials in Patients with Moderate-to...

  • October 10, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.